Reinvestigation of unidentified causative variants in FXI-deficient patients: Focus on gene segment deletions.

Given the high incidence of deletions in our population (2.9%), MLPA (or NGS with a reliable bioinformatic pipeline) should be systematically performed for unsolved FXI deficiencies or apparently homozygous cases in non-consanguineous families.